FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892219868> ?p ?o ?g. }

• W2892219868 abstract "Once aberrantly activated, the Wnt/β-catenin pathway may result in uncontrolled proliferation and eventually cancer. Efforts to counter and inhibit this pathway are mainly directed against β-catenin, as it serves a role on the cytoplasm and the nucleus. In addition, specially-generated lymphocytes are recruited for the purpose of treating liver cancer. Peripheral blood mononuclear lymphocytes are expanded by the timely addition of interferon γ, interleukin (IL)-1β, IL-2 and anti-cluster of differentiation 3 antibody. The resulting cells are called cytokine-induced killer (CIK) cells. The present study utilised these cells and combine them with drugs inhibiting the Wnt pathway in order to examine whether this resulted in an improvement in the killing ability of CIK cells against liver cancer cells. Drugs including ethacrynic acid (EA) and ciclopirox olamine (CPX) were determined to be suitable candidates, as determined by previous studies. Drugs were administered on their own and combined with CIK cells and then a cell viability assay was performed. These results suggest that EA-treated cells demonstrated apoptosis and were significantly affected compared with untreated cells. Unlike EA, CPX killed normal and cancerous cells even at low concentrations. Subsequent to combining EA with CIK cells, the potency of killing was increased and a greater number of cells died, which proves a synergistic action. In summary, EA may be used as an anti-hepatocellular carcinoma drug, while CPX possesses a high toxicity to cancerous as well as to normal cells. It was proposed that EA should be integrated into present therapeutic methods for cancer." @default.
• W2892219868 created "2018-09-27" @default.
• W2892219868 creator A5050233418 @default.
• W2892219868 creator A5053797885 @default.
• W2892219868 creator A5074477435 @default.
• W2892219868 date "2018-09-20" @default.
• W2892219868 modified "2023-09-29" @default.
• W2892219868 title "Utilizing ethacrynic acid and ciclopirox olamine in liver cancer" @default.
• W2892219868 cites W121708982 @default.
• W2892219868 cites W1700829084 @default.
• W2892219868 cites W1969939160 @default.
• W2892219868 cites W1980682169 @default.
• W2892219868 cites W1995000770 @default.
• W2892219868 cites W2017847041 @default.
• W2892219868 cites W2023192965 @default.
• W2892219868 cites W2056372251 @default.
• W2892219868 cites W2107648723 @default.
• W2892219868 cites W2108728504 @default.
• W2892219868 cites W2117349332 @default.
• W2892219868 cites W2121860547 @default.
• W2892219868 cites W2124937026 @default.
• W2892219868 cites W2127860417 @default.
• W2892219868 cites W2133114658 @default.
• W2892219868 cites W2136502909 @default.
• W2892219868 cites W2138288799 @default.
• W2892219868 cites W2145595073 @default.
• W2892219868 cites W2149682719 @default.
• W2892219868 cites W2156315219 @default.
• W2892219868 cites W2160111314 @default.
• W2892219868 cites W2166178545 @default.
• W2892219868 cites W2256432164 @default.
• W2892219868 cites W2405677741 @default.
• W2892219868 cites W2419193153 @default.
• W2892219868 doi "https://doi.org/10.3892/ol.2018.9472" @default.
• W2892219868 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6202527" @default.
• W2892219868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30405829" @default.
• W2892219868 hasPublicationYear "2018" @default.
• W2892219868 type Work @default.
• W2892219868 sameAs 2892219868 @default.
• W2892219868 citedByCount "10" @default.
• W2892219868 countsByYear W28922198682019 @default.
• W2892219868 countsByYear W28922198682020 @default.
• W2892219868 countsByYear W28922198682021 @default.
• W2892219868 countsByYear W28922198682022 @default.
• W2892219868 countsByYear W28922198682023 @default.
• W2892219868 crossrefType "journal-article" @default.
• W2892219868 hasAuthorship W2892219868A5050233418 @default.
• W2892219868 hasAuthorship W2892219868A5053797885 @default.
• W2892219868 hasAuthorship W2892219868A5074477435 @default.
• W2892219868 hasBestOaLocation W28922198681 @default.
• W2892219868 hasConcept C121608353 @default.
• W2892219868 hasConcept C126322002 @default.
• W2892219868 hasConcept C137061746 @default.
• W2892219868 hasConcept C137620995 @default.
• W2892219868 hasConcept C1491633281 @default.
• W2892219868 hasConcept C185592680 @default.
• W2892219868 hasConcept C190283241 @default.
• W2892219868 hasConcept C202751555 @default.
• W2892219868 hasConcept C203014093 @default.
• W2892219868 hasConcept C2776231280 @default.
• W2892219868 hasConcept C2778019345 @default.
• W2892219868 hasConcept C2781018059 @default.
• W2892219868 hasConcept C29537977 @default.
• W2892219868 hasConcept C502942594 @default.
• W2892219868 hasConcept C55493867 @default.
• W2892219868 hasConcept C62478195 @default.
• W2892219868 hasConcept C71924100 @default.
• W2892219868 hasConcept C86803240 @default.
• W2892219868 hasConcept C96232424 @default.
• W2892219868 hasConcept C98274493 @default.
• W2892219868 hasConceptScore W2892219868C121608353 @default.
• W2892219868 hasConceptScore W2892219868C126322002 @default.
• W2892219868 hasConceptScore W2892219868C137061746 @default.
• W2892219868 hasConceptScore W2892219868C137620995 @default.
• W2892219868 hasConceptScore W2892219868C1491633281 @default.
• W2892219868 hasConceptScore W2892219868C185592680 @default.
• W2892219868 hasConceptScore W2892219868C190283241 @default.
• W2892219868 hasConceptScore W2892219868C202751555 @default.
• W2892219868 hasConceptScore W2892219868C203014093 @default.
• W2892219868 hasConceptScore W2892219868C2776231280 @default.
• W2892219868 hasConceptScore W2892219868C2778019345 @default.
• W2892219868 hasConceptScore W2892219868C2781018059 @default.
• W2892219868 hasConceptScore W2892219868C29537977 @default.
• W2892219868 hasConceptScore W2892219868C502942594 @default.
• W2892219868 hasConceptScore W2892219868C55493867 @default.
• W2892219868 hasConceptScore W2892219868C62478195 @default.
• W2892219868 hasConceptScore W2892219868C71924100 @default.
• W2892219868 hasConceptScore W2892219868C86803240 @default.
• W2892219868 hasConceptScore W2892219868C96232424 @default.
• W2892219868 hasConceptScore W2892219868C98274493 @default.
• W2892219868 hasLocation W28922198681 @default.
• W2892219868 hasLocation W28922198682 @default.
• W2892219868 hasLocation W28922198683 @default.
• W2892219868 hasLocation W28922198684 @default.
• W2892219868 hasOpenAccess W2892219868 @default.
• W2892219868 hasPrimaryLocation W28922198681 @default.
• W2892219868 hasRelatedWork W2006805693 @default.
• W2892219868 hasRelatedWork W2193001123 @default.
• W2892219868 hasRelatedWork W2724401718 @default.
• W2892219868 hasRelatedWork W2884763177 @default.

• next